Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity
 15 Jun 2010: Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.
Cellular Dynamics International
|
Agilent Technologies Offers FT-IR Solutions for Biomedical and Biological Analysis
15 Jun 2010: Agilent Technologies Inc. today announced Fourier Transform-Infra Red (FT-IR) solutions for biomedical and biological applications that reduce analysis times and reveal more detailed information about biomedical and biological samples.
Agilent Technologies
|
Society for Biomolecular Sciences Announces Call for Papers
14 Jun 2010: The Society for Biomolecular Sciences (SBS) announced today that they are accepting abstracts for the SBS 17th Annual Conference and Exhibition, Advancing the Science of Drug Discovery, which will take place March 27- 31, 2011 at the Gaylord Palms Resort and Convention Center in Orlando, Florida.
Society for Biomolecular Sciences (SBS)
|
Lonza Introduces Clonetics® Human Retinal Pigment Epithelial Cells & RtEGM™ Growth Medium
14 Jun 2010: Lonza is pleased to announce the availability of cryopreserved Clonetics® Human Retinal Pigment Epithelial (hRPE) Cells and optimized RtEGM™ Growth Medium BulletKit® for ophthalmologic research including age-related macular degeneration, retinistis pigmentosa, and gene expression profiles of RPE.
Lonza Group Ltd
|
Thermo Fisher Scientific Extends Linear Ion Trap and Triple Stage Quadrupole Mass Spectrometer Trade-In Program
 14 Jun 2010: Thermo Fisher Scientific Inc., the world leader in serving science, announces the extension of its LC-MS ion trap and triple stage quadrupole trade-in programs to include the trade-in of instruments from any vendor. Scientists are invited to participate in the Traps and Triples Trade-In Program by trading in ion trap or triple stage quadrupole mass spectrometers – from any vendor – and upgrading to Thermo Scientific linear ion trap or triple stage quadrupole technology.
Thermo Fisher Scientific
|
UVP Announces Major Software Upgrade for VisionWorksLS Analysis Software
 14 Jun 2010: UVP, LLC announces a major upgrade to the VisionWorks®LS Software, configured with UVP’s BioImaging Systems, making this version the most streamlined, efficient design for personalized workflow. The new VisionWorksLS 7.0 software includes a redesigned interface, portable analysis data, capture templates and compatibility with Windows 7.
UVP, LLC.
|
DNASTAR Software Grant Supports Ion Torrent Awards
11 Jun 2010: DNASTAR® announced today that it will join Ion Torrent in supporting the Ion PGM Sequencer Grant Program by providing perpetual licenses of its next-gen sequencing suite of software tools to the two European winners of the recently announced extension of the grant program.
DNASTAR Inc.
|
VLife introduces GQSAR and SCOPE: Promising Perspective to New Molecule Design and Lead Optimization
 11 Jun 2010: VLife Sciences Technologies introduces two novel methods, SCOPE and GQSAR, for new molecule design and lead optimization. SCOPE, Structure-based compound optimization prioritization and evolution is designed to overcome challenges in lead optimization. GQSAR (group based QSAR) is a patent pending methodology that simplifies the conventional QSAR approaches by mitigating interpretation challenges.
VLife Sciences Technologies Pvt. Ltd.
|
Accuri and eBioscience - Two Leading Suppliers Team Up
10 Jun 2010: Accuri is pleased to announce a co-marketing agreement with eBioscience. The collaboration is designed to offer scientists a better, and more comprehensive, solution for their flow cytometry research needs in the US and Europe. The agreement pairs the cost-effectiveness, ease-of-use, performance capabilities and accessibility of the Accuri C6 Flow Cytometer® System with the market-leading line of over 11,000 cell analysis reagents offered by eBioscience.
Accuri Cytometers, Inc.
|
Fluidigm Introduces World's First Reusable Biochip Architecture
 09 Jun 2010: Fluidigm Corporation has announced it has developed the world's first reusable bio-chip architecture for the commercial market. These reusable integrated fluidic circuits (IFCs) will dramatically lower SNP genotyping costs and are designed to support accelerated sample throughput, while maintaining data quality of 99.75 percent or greater accuracy and 99 percent or greater call rates.
Fluidigm Corporation
|
